|
It is normal for
Xylazil-100 to cause cardiopulmonary depression manifested by a decrease in
heart rate, stroke volume, cardiac output and respiratory rate together with
an increase in total peripheral resistance. These effects are transitory and
of no clinical significance in healthy horses. However, it is not
recommended to use Xylazil-100 where there is cardiovascular disease
including conditions of shock or respiratory depression.
A number of cardiac
dysrhythmias such as second degree atrioventricular blocks have been
encountered with xylazine administration and it is believed that increased
vagal tone is responsible for these. Premedication with atropine sulphate
will help prevent their occurrence although care must be taken, as atropine
sulphate is known to be associated with colic in the Horse.
Xylazil-100 should not be
administered to mares in the last trimester of pregnancy as it may
precipitate an early parturition of abortion due to its oxytocic effect on
the uterus.
Xylazil-100 should not be
administered intra-arterially.
Painful stimuli may cause
an apparently deeply sedated patient to react inappropriately and therefore
adequate care should be taken. |